RYE, N.Y., May 2, 2011 /PRNewswire/ -- Dr. Joan Fallon, CEO of Curemark LLC, will be honored on Friday June 17th at a gala held at the United Nations in New York City. The black tie event sponsored by the Knights of York is to raise funds for the New York Child Learning Institute and the Phoenix Center, both special educational centers for children with autism and other disabilities. At the event, Dr. Fallon will be presented with the Knights of York Lawrence Ferrara Children's Advocate Award.
"I am grateful to the Knights of York for this honor," stated Dr. Fallon. "It is grand to be included among such distinguished honorees who have dedicated their lives to children. The support of children with autism is so important, and to have this event at the United Nations in support of educating children with autism is quite fitting."
Also being honored at the gala are: Carol Laurenzano, Director, New York Yankees; Lauren and Jim Watkins, anchor PIX11 and autism advocate; and Bob Hurley Sr., coach of St Anthony's of Jersey City.
The Knights of York is a nonprofit organization dedicated to providing financial support for medical research, education, and community projects which benefit children in need. The organization works to fund lesser known causes, such as individual institutions so that in many cases children can benefit directly from their work.
Curemark is a drug research and development company focused on the treatment of neurological diseases. The company currently is conducting Phase III clinical trials for its autism treatment CM-AT.
About CUREMARK LLC
Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about our innovative science, visit www.curemark.com.
SOURCE Curemark LLC